Lake Forest, CALIFORNIA1 Active Studies

Familial Hypercholesterolemia Clinical Trials in Lake Forest, CALIFORNIA

Find 1 actively recruiting familial hypercholesterolemia clinical trials in Lake Forest, CALIFORNIA. Connect with local research sites and explore new treatment options.

1
Active Trials
1
Sponsors
405
Enrolling

Recruiting Familial Hypercholesterolemia Studies in Lake Forest

About Familial Hypercholesterolemia Clinical Trials in Lake Forest

Familial hypercholesterolemia is a genetic condition causing very high LDL cholesterol levels from birth, dramatically increasing the risk of early heart disease. It affects about 1 in 250 people. Treatment includes high-intensity statins, PCSK9 inhibitors, and lifestyle modifications.

There are currently 1 familial hypercholesterolemia clinical trials recruiting participants in Lake Forest, CALIFORNIA. These studies are seeking a combined 405 participants. Research is being sponsored by AstraZeneca. Clinical trial participation is free and participants receive study-related medical care at no cost.

Familial Hypercholesterolemia Clinical Trials in Lake Forest — FAQ

Are there familial hypercholesterolemia clinical trials in Lake Forest?

Yes, there are 1 familial hypercholesterolemia clinical trials currently recruiting in Lake Forest, CALIFORNIA. Browse the studies on this page to find one that fits.

How do I join a clinical trial in Lake Forest?

Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Lake Forest research site will contact you about next steps.

Are clinical trials in Lake Forest free?

Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Lake Forest studies also compensate for your time and travel.

What familial hypercholesterolemia treatments are being tested?

The 1 active trials in Lake Forest are testing new therapies including novel drugs, biologics, and treatment approaches for familial hypercholesterolemia.

Data updated March 2, 2026 from ClinicalTrials.gov